rewarding to aversive in the ventral tegmental area. Behav Pharmacol
12 [Suppl 1]:S57.
Laviolette SR, van der Kooy D (2001b) GABAA receptors in the ventral
tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems. Eur
J Neurosci 13:1009 –1015.
Laviolette SR, van der Kooy D (2002) Blockade of mesolimbic dopamine transmission dramatically potentiates nicotine reward sensitivity
in the ventral tegmental area. Mol Psychiatry, in press.
Laviolette SR, Priebe RPM, Yeomans JS (2000) Role of the laterodorsal
tegmental nucleus in scopolamine and amphetamine-induced locomotion and stereotypy. Pharmacol Biochem Behav 65:163–174.
Laviolette SR, Nader K , van der Kooy D (2002) Motivational state
determines the f unctional role of the mesolimbic dopamine system in
the mediation of opiate reward processes. Behav Brain Res 129:17–29.
Leri F, Franklin K BJ (1998) Learning impairments caused by lesions to
the pedunculopontine tegmental nucleus: an artifact of anxiety? Brain
Res 807:187–192.
Leri F, Franklin K BJ (2000) Diazepam modifies the effect of pedunculopontine lesions on morphine but not on amphetamine conditioned
place preference. Behav Brain Res 117:21–27.
Mansvelder H D, Keath JR, McGehee DS (2002) Synaptic mechanisms
underlie nicotine-induced excitability of brain reward areas. Neuron
33:905–919.
Mathur A, Shandarin A, Laviolette SR, Parker J, Yeomans JS (1997)
L ocomotion and stereotypy induced by scopolamine: contributions of
muscarinic receptors near the pedunculopontine tegmental nucleus.
Brain Res 775:144 –155.
Nader K , van der Kooy D (1997) Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental
area. J Neurosci 17:383–390.
Oakman SA, Faris PL, Kerr PE, Cozzari C, Hartman BK (1995) Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to the ventral
tegmental area. J Neurosci 15:5859 –5869.
Olmstead MC, Franklin K BJ (1994) Lesions of the pedunculopontine
tegmental nucleus block drug-induced reinforcement but not
amphetamine-induced locomotion. Brain Res 638:29 –35.
Olmstead MC, Munn EM, Franklin K B, Wise R A (1998) Effects of
pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci
18:5035–5044.
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, Ed
2. New York: Academic.
Podhorna J, Franklin K BJ (1998) Lesions of the pedunculopontine tegmental nucleus increase anxiety in rats. NeuroReport 9:1783–1786.
Rose JE, Corrigall WA (1997) Nicotine self-administration in animals
and humans: similarities and differences. Psychopharmacology 130:
28 – 40.
Semba K , Fibiger HC (1992) Afferent connections of the laterodorsal
and pedunculopontine tegmental nuclei in the rat: a retro- and anterograde transport and immunohistochemical study. J Comp Neurol
323:387– 410.
Stef urak TL, van der Kooy D (1992) Saccharin's rewarding, conditioned
reinforcing, and memory-improving properties: mediation by isomorphic or independent processes? Behav Neurosci 106:125–139.
Stef urak TL, van der Kooy D (1994) Tegmental pedunculopontine le- sions in rats decrease saccharin's rewarding effects but not its memory
improving effect. Behav Neurosci 108:972–980.
Steininger TL, Rye DB, Wainer BH (1992) Afferent projections to the
cholinergic pedunculopontine tegmental nucleus and adjacent midbrain
extrapyramidal area in the albino rat. 1. Retrograde tracing studies.
J Comp Neurol 321:515–543.
Swanson LW (1982) The projections of the ventral tegmental area and
adjacent regions: a combined fluorescent and retrograde tracer and
immunofluorescence study in the rat. Brain Res Bull 9:321–353.
Vincent SR, Satoh K , Armstrong DM, Fibiger HC (1983) NADPHdiaphorase: a selective histochemical marker for the cholinergic neurons of the pontine reticular formation. Neurosci Lett 43:31–36.
Woolf NJ (1991) Cholinergic systems in mammalian brain and spinal
cord. Prog Neurobiol 37:475–524.
Yeomans JS, Takeuchi J, Baptista M, Flynn DD, Lepik K , Nobrega J,
Fulton J, Ralph MR (2000) Brain-stimulation reward thresholds
raised by an antisense oligonucleotide for the M5 muscarinic receptor
inf used near dopamine cells. J Neurosci 20:8861– 8867.
Z arrindast MR, Homayoun H, Babaie A, Etminani A, Gharib B (2000)
Involvement of adrenergic and cholinergic systems in nicotine-induced
anxiogenesis in mice. Eur J Pharmacol 407:145–158.
